top of page

Applications are open for the 2023 Bridge Program

09/02/23 - Expand your commercialisation experience, knowledge and networks in 2023.

Fully funded by MTPConnect and a consortium of industry and university partners, the Bridge Program is a training program that helps participants to navigate the pharmaceutical commercialisation pathway. Participants join one of Australia's most significant pharmaceutical and biotech networks.

Why participate in the Bridge Program

Gain confidence, create networks and opportunities in all areas of pharmaceutical research commercialisation. You will:

  • Learn through online modules

  • Attend an inspiring seminar series

  • Take part in collaborative activities including real-life pitching experiences

  • Network with top pharma companies and a nation-wide professional community.

Course fees are covered by our partner organisations.

Who should apply

The program is suited to professionals looking to expand their commercialisation experience, knowledge and networks in the Australian pharmaceutical industry, including:

  • Researchers

  • Scientists

  • Entrepreneurs

  • Legal practitioners (including IP and patents)

  • Clinicians

  • Venture capitalists

  • Business development personnel

  • Staff from regulatory and government agencies.

Applications are now open, closing February 28, 2023.



bottom of page